223 results
8-K
EX-99.1
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
options. Beyond financial investment, G2G Ventures provides accretive consulting services to help clarify strategic goals and key performance indicators … . Forward-looking statements include our expectations regarding the Company’s progress, strategic options, business goals, and other matters. These forward
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
16 Nov 23
Entry into a Material Definitive Agreement
4:55pm
Goals” means, for a Performance Period, the one or more goals established by the Committee for the Performance Period based upon business criteria … fiscal quarter in duration], as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose
8-K
EX-99.1
4zxsm
28 Jul 23
Departure of Directors or Certain Officers
5:10pm
8-K
EX-99.1
zbao9ejbbg61h13
13 Jul 23
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
5:27pm
8-K
EX-99.1
pl6yw6j3s
6 Jul 23
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
4:39pm
8-K
EX-99.1
t0b wkd5gfbn
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
8-K
EX-99.1
oodqnn6 dqjm
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-99.2
uxhrnpppmzykb9
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-99.1
j1dv84o68l0xq6w 9r21
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
rs83d
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
8-K
EX-99.1
uwcivnzno 29
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
S-8
EX-10.1
xhk vhc73
22 Dec 22
Registration of securities for employees
4:19pm